These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38122867)

  • 1. Endophthalmitis after Anti-VEGF Intravitreal Injections with Aqueous Chlorhexidine versus Povidone-Iodine as Ocular Antiseptics.
    Ton NS; Goncharov V; Zapata I; Adam MK
    Ophthalmol Retina; 2024 Jun; 8(6):521-526. PubMed ID: 38122867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous Chlorhexidine Compared with Povidone-Iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial.
    Ali FS; Jenkins TL; Boparai RS; Obeid A; Ryan ME; Wibblesman TD; Chiang A; Garg SJ;
    Ophthalmol Retina; 2021 Aug; 5(8):788-796. PubMed ID: 33221515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
    Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S;
    Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    ; Patel SN; Tang PH; Storey PP; Wolfe JD; Fein J; Shah SP; Chen E; Abbey A; Ferrone PJ; Shah CP; Liang MC; Stem MS; Ali Khan M; Yonekawa Y; Garg SJ
    Ophthalmology; 2021 Nov; 128(11):1620-1626. PubMed ID: 34019955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Endophthalmitis Rates after Alcohol-Based Chlorhexidine and Povidone-Iodine Antisepsis for Intravitreal Injections.
    Mishra AV; Tong CM; Faes L; Cheema MK; Plemel D; Rubin U; Bao B; Nazarali S; Lapere SRJ; Somani R; Hinz BJ; Tennant MTS
    Ophthalmol Retina; 2024 Jan; 8(1):18-24. PubMed ID: 37611695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
    Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP
    Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endophthalmitis After Intravitreal Injections in Patients With Self-reported Iodine Allergy.
    Modjtahedi BS; van Zyl T; Pandya HK; Leonard RE; Eliott D
    Am J Ophthalmol; 2016 Oct; 170():68-74. PubMed ID: 27448925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
    Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous Chlorhexidine for Intravitreal Injection Antisepsis: A Case Series and Review of the Literature.
    Merani R; McPherson ZE; Luckie AP; Gilhotra JS; Runciman J; Durkin S; Muecke J; Donaldson M; Aralar A; Rao A; Davies PE
    Ophthalmology; 2016 Dec; 123(12):2588-2594. PubMed ID: 27720552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength.
    Stem MS; Rao P; Lee IJ; Woodward MA; Faia LJ; Wolfe JD; Capone A; Covert D; Dass AB; Drenser KA; Garretson BR; Hassan TS; Margherio A; Oh KT; Raephaelian PV; Randhawa S; Sneed S; Trese MT; Yedavally S; Williams GA; Ruby AJ
    Ophthalmol Retina; 2019 Jan; 3(1):3-7. PubMed ID: 30929813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study of Microbiological Profile and Management Outcomes of Acute Endophthalmitis after Microincision Vitrectomy Surgery versus Intravitreal Injections.
    Kannan NB; Sen S; Mishra C; Lalitha P; Rameshkumar G; Rajan RP; Arumugam KK; Ramasamy K
    Ocul Immunol Inflamm; 2021 Jul; 29(5):838-844. PubMed ID: 31900009
    [No Abstract]   [Full Text] [Related]  

  • 13. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
    Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
    Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
    Bhatt SS; Stepien KE; Joshi K
    Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.
    Rayess N; Obeid A; Storey PP; Juliano J; Rahimy E; Moshfeghi AA; Garg S; Hsu J
    Retina; 2019 Nov; 39(11):2070-2076. PubMed ID: 30157114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lid splinting eyelid retraction technique: a minimised sterile approach for intravitreal injections.
    Munro M; Williams GR; Ells A; Fielden M; Kherani A; Mitchell P; Ruzicki J; Adatia FA
    Br J Ophthalmol; 2018 Sep; 102(9):1254-1258. PubMed ID: 29246893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity.
    Mulcahy LT; Schimansky S; Fletcher E; Mohamed Q
    Eye (Lond); 2021 Jun; 35(6):1651-1658. PubMed ID: 32839557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recurrent povidone-iodine usage on conjunctival flora in diabetic patients undergoing intravitreal injections.
    Einan-Lifshitz A; Sorkin N; Smollan G; Barequet I
    Eur J Ophthalmol; 2021 Mar; 31(2):607-611. PubMed ID: 31983226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Patel SN; Hsu J; Sivalingam MD; Chiang A; Kaiser RS; Mehta S; Park CH; Regillo CD; Sivalingam A; Vander JF; Ho AC; Garg SJ;
    Am J Ophthalmol; 2021 Feb; 222():194-201. PubMed ID: 32888902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period.
    Pancholy M; Storey PP; Levin HJ; Obeid A; Patel SN; Kuley B; Hsu J; Spirn MJ; Fineman M; Klufas MA; Gupta O; Ho AC; Garg SJ
    Curr Eye Res; 2021 Sep; 46(9):1370-1377. PubMed ID: 33522314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.